LPL activity and molecular diagnosis.

<p>$ 3 diabetic compound heterozygous patients ([p.Q139X];[p.S19W polymorphism]); * patient with anti-LPL antibodies and heterozygous mutation of <i>LPL</i> gene; £ Triglyceridemia determined the day of LPL activity measurement.</p

Subjects features.

<p>n effective of the group.</p><p>NA not available.</p><p>Mean (range) or %.</p

Correlation between LPL activity assays in TVHTG and controls patients.

<p>Figure 2A. Correlation with conventional method (n  =  26, r  =  0.88, p<0.001). y = 8.93× + 1.21; R² = 0.77. Figure 2B. Distribution of LPL activity in TVHTG patients and controls subjects. TVHTG patients (grey square); controls (black square).</p

Kinetics and linearity.

<p>Figure 1A. PHLA and HL kinetics in 3 patients. LPL+HL (line); HL (dotted line); Patient 1 (triangle); Patient 2 (circle); Patient 3 (square); Patient 4 (vertical line). Figure 1B. Linearity test. Patient 1(black diamond); Patient 2 (white square); Patient 3 (grey triangle); Patient 4 (black square); Patient 5 (grey square); Patient 6 (grey circle).</p